Compare MDXG & ACDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MDXG | ACDC |
|---|---|---|
| Founded | 2006 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oilfield Services/Equipment |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 625.6M | 1.1B |
| IPO Year | 2007 | 2021 |
| Metric | MDXG | ACDC |
|---|---|---|
| Price | $4.69 | $4.62 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 6 | 2 |
| Target Price | ★ $9.00 | $5.50 |
| AVG Volume (30 Days) | 911.6K | ★ 1.1M |
| Earning Date | 04-29-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 14.29 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $418,630,000.00 | ★ $1,941,800,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $13.02 | $11.50 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 19.99 | N/A |
| 52 Week Low | $3.03 | $3.08 |
| 52 Week High | $7.97 | $8.22 |
| Indicator | MDXG | ACDC |
|---|---|---|
| Relative Strength Index (RSI) | 66.69 | N/A |
| Support Level | $4.11 | N/A |
| Resistance Level | $5.38 | N/A |
| Average True Range (ATR) | 0.17 | 0.00 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 88.74 | 0.00 |
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
ProFrac Holding Corp is a technology-focused, vertically integrated energy services company providing hydraulic fracturing, proppant production, completion services, and related products, including distributed power generation, to upstream oil and natural gas companies in the United States. The Company operates through four segments: Stimulation Services, Proppant Production, Manufacturing, and Flotek. The Stimulation Services segment, which generates maximum revenue, provides hydraulic fracturing services using mobile units and auxiliary equipment. The Proppant Production segment supplies proppant, the Manufacturing segment sells engineered products such as pumps, valves, and piping, and Flotek is a chemistry and data technology company serving the E&P industry.